Plasminogen Activator Inhibitor-1 in Asthma

참고문헌 (107)

1. "Holgate ST. Subepithelial fibrosis in the bronchi of asthmatics. Lancet 1989", pp.520~4
2. "Takashima T. Marked goblet cell hyperplasia with mucus accumulation in the airways of patients who died of severe acute asthma attack. Chest 1992", pp.916~21
3. "Hossain S. Hyperplasia of bronchial muscle in asthma. J Pathol 1973", pp.319~31
4. "Motomiya M. Cellular hypertrophy and hyperplasia of airway smooth muscles underlying bronchial asthma", pp.720~6
5. "Airway remodeling in asthma", 104, pp.1001~1006 (1999)
6. "Airway remodeling and repair", 160, pp.1035~1042 (1999)
7. "Jensen GN. A 15-year follow-up study of ventilatory function in adults with asthma. N Engl J Med 1998", sch(hr p), pp.1194~200
8. "Haahtela T. A comparative study of the effects of an inhaled corticosteroid on airway inflammation in newly diagnosed asthma", pp.32~42
9. "Fluticasone inhibits but does not reverse allergen-induced structural airway changes", 163, pp.674~679 (2000)
10. "The plasminogen fibrinolytic system", 82, pp.259~270 (1999)
11. "Bleomycin-induced pulmonary fibrosis in transgenic mice that either lack or overexpress the murine plasminogen activator inhibitor-1 gene", 97, pp.232~237 (1996)
12. "PAI-1 promotes extracellular matrix deposition in the airways of a murine asthma model", 294, pp.1055~1060 (2002)
13. "Possible role of the 4G", 5G polymorphism of the plasminogen activator inhibitor 1 gene in the development of asthma, 2001, pp.108(2), 212~214
14. "Polymorphism 4G", 5G in the plasminogen activator inhibitor-1 (PAI-1) gene is associated with IgE-mediated allergic diseases and asthma in the Czech population, 2002, pp.57(5), 446~448
15. "Bethesda, MD: National Institutes of Health, National Heart, Lung and Blood Institute Publication", (95)
16. "Tsai M. For better or for worse does stem cell factor importantly regulate mast cell function in pulmonary physiology and pathology", pp.644~5
17. "Mast cells can amplify airway reactivity and features of chronic inflammation in an asthma model in mice", 192(3), pp.455~462 (2000)
18. "Mast cells play a partial role in allergen-induced subepithelial fibrosis in a murine model of allergic asthma", 33(5), pp.705~713 (2003)
19. "Biochemical mediators of allergic reactions. In: Patterson R, Grammer LC, Greenberger PA, Ed", pp.49~56 (1997), JB Lippincott
20. "Schechter NM. Quantitation of histamine and chymase in dispersed human T and TC mast cells. J Immunol 1987", pp.2611~5
21. "PAF induced airways hyperreactivity is modulated by mast cells in mice", 14, pp.461~469 (1996)
22. "The immediate phase of c-kit ligand stimulation of mouse bone marrow-derived mast cells elicits rapid leukotriene C4 generation through post-translational activation of cytosolic phospholipase A2 and 5-lipoxygenase", pp.197~206 (1995)
23. "Hunninghake GW. Direct evidence of a role for mast cells in the pathogenesis of antigen induced bronchoconstriction. J Clin Invest 1987", pp.1507~11
24. "Increased urinary excretion of the prostaglandin D2 metabolites 9α, 11β- prostaglandin F2 after aspirin challenge supports mast cell activation in aspirin-induced airway obstruction", 98, pp.421~432 (1996)
25. "Goetzl EJ. Oxygenation products of arachinonic acid as mediators of hypersensitivity and inflammation. Med Clin North Am 1981", pp.809~28
26. "From slow reacting substance of anaphylaxis to leukotriene C4 synthase", 107, pp.19~24 (1995)
27. "Lee TH. Sulphidopeptide leukotrienes in asthma. Clin Sci 1993", pp.501~10
28. "Overexpression of leukotriene C4 synthase in bronchial biopsies from patients with aspirin-intolerant asthma", 101, pp.834~846 (1998)
29. "Leukotriene antagonists and synthesis inhibitors: new direction in asthma therapy", 98, pp.1~13 (1996)
30. "Transmigration of eosinophils through basement membrane components in vitro: synergistic effect of PAF and eosinophil active cytokines", 16, pp.455~463 (1997)
31. "Platelet activating factor acetylhydrolase deficiency: a missense mutation in the active site of an antiinflammatory phospholipase", 97, pp.2784~2791 (1996)
32. "Effects of a PAF antagonist Y24180 on bronchial responsiveness in patients with asthma", 152, pp.1198~1202 (1995)
33. "Paul WE. Mast cell lines produce lymphokines in response to cross-linkage of Fce RI or calcium ionophore. Nature 1989", pp.64~7
34. "Moroni C. Production of the haemopoietic growth factors GM-CSF and interleukin-3 by mast cells in response to IgE receptor-mediated activation. Nature 1989", pp.150~2
35. "et al. Interleukin 3-dependent and -independent mast cells stimulated with IgE and antigen express multiple cytokines. J Exp Med 1989", pp.245~57
36. "Galli SJ. Mast cells as a source of both preformed and immunologically inducible TNF-α", cachectin. Nature 1990, 274~6
37. "et al. Predominant Th2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med 1992", pp.298~304
38. "Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-αlpha", 381, pp.77~80 (1996)
39. "Critical protective role of mast cells in a model of acute septic peritonitis", 381, pp.75~77 (1996)
40. "Galli SJ. Release of both preformed and newly synthesized tumor necrosis factor alpha", cachectin by mouse mast cells stimulated via the FcRI a mechanism for the sustained action of mast cell-derived TNF-α during IgE-dependent biological responses. J Exp Med 1991, 103~7
41. "-6 and tumor necrosis factor- alpha in normal and asthmatic airways evidence for the human mast cells as a source of these cytokines. Am J Respir Cell Mol Biol 1994", djuka(vic r), pp.471~4 80
42. "Constitutive and inducible cytokine mRNA xpression in the human mast cell line HMC-1", 42, pp.76~81 (1995)
43. "Lymphotactin gene expression in mast cells following Fc(epsilon) receptor I aggregation: modulation by TGF-beta, IL-4, dexamethasone, and cyclosporin A", 158, pp.1353~1360 (1997)
44. "Metcalfe DD. Transcriptional regulation of the TCA3 gene in mast cells after Fc epsilon RI cross-linking. J Immunol 1994", pp.325~32
45. "Activated lymphocytes induce promoter activity of the TCA3 gene in mast cells following cell-to-cell contact", 221, pp.510~514 (1996)
46. "Two different negative regulatory elements control the transcription of T-cell activation gene 3 in activated mast cells", 323, pp.511~519 (1997)
47. "Galli SJ. Promotion of mouse fibroblast collagen gene expression by mast cells stimulated via the FcRI role for mast cell-derived transforming growth factor and tumor necrosis factor. J Exp Med 1994", pp.2027~37
48. "A novel heparin-dependent processing pathway for human tryptase", 97, pp.988~995 (1996)
49. "Caughey GH. Degradation of neuropeptides by human lung tryptase. Am J Respir Cell Mol Biol 1992", pp.27~32
50. "Mast cell tryptase: hoisted by its own petard?", 97, pp.895~896 (1996)
51. "Caughey GH. Mast cell tryptase is mitogen for cultured fibroblasts. J Clin Invest 1991", pp.493~9
52. "Tryptase, the dominant secretory granular protein in human mast cell, is a potent mitogen for cultured dog tracheal smooth muscle cells", 13, pp.227~236 (1995)
53. "Bronchial responsiveness to distilled water and methacholine and its relationship to inflammation and remodeling of the airways in asthma", 153, pp.910~917 (1996)
54. "Mast cell expression of gelatinases A and B is regulated by kit ligand and TGF-beta", 162, pp.5528~5535 (1999)
55. "Human mast cells produce matrix metalloproteinase 9", 29, pp.2645~2649 (1999)
56. "Mast Cell Tissue Inhibitor of Metalloproteinase-1 Is Cleaved and Inactivated Extracellularly by alpha-Chymase", 166, pp.2783~2792 (2001)
57. "Quantitative monitoring of gene expression patterns with a complementary DNA microarray", 270, pp.467~470 (1995)
58. "A DNA microarray system for analyzing complex DNA samples using two-color fluorescent probe hybridization", 6, pp.639~645 (1996)
59. "Identification and categorization of inducible mast cell genes in a subtraction library", 242, pp.226~230 (1998)
60. "Identification and characterization of the inducible murine mast cell gene, imc-415", 252, pp.123~127 (1998)
61. "Production of plasminogen activator inhibitor-1 by human mast cells and its possible role in asthma", 165, pp.3154~3161 (2000)
62. "Exploring the interface between metalloproteinase activity and growth factor and cytokine bioavailability", 13, pp.277~287 (2002)
63. "How matrix metalloproteinases regulate cell behavior", 17, pp.463~516 (2001)
64. "Epilysin, a novel human matrix metalloproteinase (MMP-28) expressed in testis and keratinocytes and in response to injury", 276, pp.10134~10144 (2001)
65. "Matrix metalloproteinases: Implication in vascular matrix remodelling during atherogenesis", 94, pp.103~110 (1998)
66. "Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3", 85, pp.683~693 (1996)
67. "from HT 1080 human fibrosarcoma cells. Purification and activation of the precursor and enzymic properties. J Biol Chem 1992", go(ji y), pp.92 21712~9
68. "Nagase H. Mechanisms of activation of tissue procollagenase by matrix metalloproteinase 3", pp.10261~70
69. "Vaes G. Further studies on the activation of procollagenase the latent precursor of bone collagenase. Effects of lysosomal cathepsin B", pp.21~31
70. "et al. Tissue cooperation in a proteolytic cascade activating human interstitial collagenase.Proc Natl Acad Sci USA 1989", pp.2632~6
71. "Stromelysin-1 (MMP-3)-independent gelatinase expression and activation in mice", 91(6), pp.2045~2053 (1998)
72. "Vartio T. Proteolytic processing of the 72 000-Da type IV collagenase by urokinase plasminogen activator. Exp Cell Res 1992", pp.471~6
73. "activates the precursor for the human matrix metalloproteinase 9. J Biol Chem 1992", pp.3581~4
74. "Urokinase is required for the pulmonary inflammatory response to Cryptococcus neoformans. A murine transgenic model", 97(8), pp.1818~1826 (1996)
75. "Induction of primary cutaneous melanocytic neoplasms in urokinase-type plasminogen activator (uPA)-deficient and wild-type mice: cellular blue nevi invade but do not progress to malignant melanoma in uPA-deficient animals", 56(15), pp.3597~3604 (1996)
76. "Urokinase receptor (CD87) regulates leukocyte recruitment via beta 2 integrins in vivo", 188(6), pp.1029~1037 (1998)
77. "Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization", 4(8), pp.923~928 (1998)
78. "Blasi F. Accessibility of receptor-bound urokinase to type-1 plasminogen activator inhibitor. Proc Natl Acad Sci USA 1989", pp.4828~32
79. "et al. Activation of pro-urokinase and plasminogen on human sarcoma cells a proteolytic system with surface-bound reactants. J Cell Biol 1989" (1987), Tapiovaara H
80. "Is plasminogen activator inhibitor-1 the molecular switch that governs urokinase receptor-mediated cell adhesion and release?", 134(6), pp.1563~1571 (1996)
81. "The serpin PAI-1 inhibits cell migration by blocking integrin alpha V beta 3 binding to vitronectin", 383(6599), pp.441~443 (1996)
82. "Plasminogen activator inhibitor-1 represses integrin- and vitronectin-mediated cell migration independently of its function as an inhibitor of plasminogen activation", 232(2), pp.420~429 (1997)
83. "Sp1 sites mediate activation of the plasminogen activator inhibitor-1 promoter by glucose in vascular smooth muscle cells", 273(14), pp.8225~8231 (1998)
84. "Loskutoff DJ. Identification of regulatory sequences in the type 1 plasminogen activator inhibitor gene responsive to transforming growth factor beta. J Biol Chem 1991", pp.23048~52
85. "Henney AM. The two allele sequences of a common polymorphism in the promoter of the plasminogen activator inhibitor-1 gene respond differently to interleukin-1 in HepG2 cells. J Biol Chem 1993", pp.10739~1 45
86. "Direct binding of Smad3 and Smad4 to critical TGF beta- inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene", 17, pp.3091~3100 (1998)
87. "Type 1 plasminogen activator inhibitor gene: functional analysis and glucocorticoid regulation of its promoter", 85, pp.5525~5529 (1998)
88. "Loskutoff DJ. Cytokine activation of vascular endothelium. Effects on tissue-type plasminogen activator and type 1 plasminogen activator inhibitor. J Biol Chem 1988", pp.5797~803, Gimbrone MA Jr
89. "et al. Tumor necrosis factor-α increases antifibrinolytic activity of cultured human mesangial cells. Kidney Int 1992", pp.327~34
90. "Direct binding of Smad3 and Smad4 to critical TGFβ-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene", 17, pp.3091~3100 (1998)
91. "Role of c-Jun and proximal phorbol 12-myristate-13-acetate-(PMA)- responsive elements in the regulation of basal and PMA-stimulated plasminogen-activator inhibitor-1 gene expression in HepG2", 241(2), pp.393~402 (1996)
92. "Natriuretic factors and nitric oxide suppress plasminogen activator inhibitor-1 expression in vascular smooth muscle cells. Role of cGMP in the regulation of the plasminogen system", 18(11), pp.1771~1779 (1998)
93. "Lovastatin modulates in vivo and in vitro the plasminogen activator", plasmin system of rat proximal tubular cells: role of geranylgeranylation and Rho proteins, 1998, pp.9(8), 1377~1388
94. "IFN-gamma inhibits thrombin- and endotoxin-induced plasminogen activator inhibitor type 1 in human endothelial cells", 157(6), pp.2610~2617 (1996)
95. "Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction", 14 92(6), pp.1851~1855 (1995)
96. "PAI-1, fibrosis, and the elusive provisional fibrin matrix", 106(12), pp.1441~1443 (2000)
97. "Consequences of long-term inflammation. Airway remodeling", 21(2), pp.331~343 (2000)
98. "Dynamics of matrix turnover during pathologic remodeling of the extracellular matrix", 148, pp.1345~1350 (1996)
99. "Airway remodeling in asthma", 104(8), pp.1001~1006 (1999)
100. "et al. Depressed bronchoalveolar urokinase activity in patients with adult respiratory distress syndrome. N Engl J Med 1990", pp.890~7
101. "et al. Local abnormalities in coagulation and fibrinolytic pathways predispose to alveolar fibrin deposition in the adult respiratory distress syndrome. J Clin Invest 1989", pp.695~705
102. "Weibel ER. Alterations of the gas exchange apparatus in adult respiratory insufficiency associated with septicemia. Am Rev Respir Dis 1977", pp.589~615
103. "Stone OL. Abnormalities in pathways of alveolar fibrin turnover among patients with interstitial lung disease. Am Rev Respir Dis 1986", pp.437~43
104. "Sitrin RG. Procoagulant and plasminogen activator activities of bronchoalveolar fluid in patients with pulmonary sarcoidosis. Exp Lung Res 1988", pp.261~78
105. "et al. Disordered pathways of fibrin turnover in lung lavage of premature infants with respiratory distress syndrome. Am Rev Respir Dis 1992", pp.492~99
106. "Coalson JJ. Fibrinolytic activity in bronchoalveolar lavage of baboons with diffuse alveolar damage trends in two forms of lung injury. Crit Care Med 1992", pp.1431~40
107. "PAI-1 promotes extracellular matrix deposition in the airways of a murine asthma model", 294(5), pp.1155~1160 (2002)

관련 논문AI추천